SCHEMBL2236723

SCHEMBL2236723

Cc1ccc(-c2cc(N3CCNC3=O)ccc2S(=O)(=O)O)cc1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.34
RAB9A P51151 1/20 0.34
ALOX5 P09917 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
PTGS1 P23219 1/20 0.34
PTGS2 P35354 1/20 0.34
DPP4 P27487 1/20 0.34
CCNA2 P20248 3/20 0.33
CDK2 P24941 3/20 0.33
CCNA1 P78396 3/20 0.33
MEN1 O00255 2/20 0.33
POLB P06746 1/20 0.33
ALDH1A1 P00352 1/20 0.33
EIF2AK2 P19525 1/20 0.33
CYP2D6 P10635 1/20 0.33
MPL P40238 1/20 0.33
TDO2 P48775 1/20 0.33
PARP1 P09874 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14119541 0.93 SMN1; SMN2 (0.40) KMT2AALOX5SMN1; SMN2MEN1ALDH1A1
SCHEMBL2304343 0.90 CCNA2 (0.33) KMT2AALOX5CCNA2CDK2CCNA1
SCHEMBL2300754 0.89 ALDH1A1 (0.35) KMT2ASMN1; SMN2CCNA2CDK2CCNA1
SCHEMBL2303530 0.89 PDK2 (0.34) KMT2ACCNA2CDK2CCNA1MEN1
SCHEMBL2307068 0.89 TDO2 (0.40) POLBALDH1A1EIF2AK2TDO2PARP1
SCHEMBL2297980 0.88 PKM (0.36) KMT2ARAB9AALOX5PTGS2MEN1
SCHEMBL2306916 0.88 TDO2 (0.35) KMT2ACCNA2CDK2CCNA1MEN1
SCHEMBL2237662 0.88 PTGS2 (0.37) ALOX5SMN1; SMN2PTGS1PTGS2DPP4
SCHEMBL2303927 0.88 EIF2AK2 (0.43) KMT2AALOX5CCNA2CDK2CCNA1
SCHEMBL2307898 0.87 LMNA (0.36) KMT2ASMN1; SMN2PTGS1PTGS2CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9034888-B2 Substituted 2-imidazolidones and analogs UNIVERSITE LAVAL (CA) 2015-05-19 US disclosed
EP-2536693-A1 SUBSTITUTED 2-IMIDAZOLIDONES AND ANALOGS Université Laval (CA) 2012-12-26 EP disclosed
US-20120309777-A1 SUBSTITUTED 2-IMIDAZOLIDONES AND ANALOGS UNIVERSITE LAVAL (CA) 2012-12-06 US disclosed
WO-2011100840-A1 SUBSTITUTED 2-IMIDAZOLIDONES AND ANALOGS UNIVERSITé LAVAL (CA) 2011-08-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120309777-A1 SUBSTITUTED 2-IMIDAZOLIDONES AND ANALOGS CCNY, RPS4Y1, TPX2 KMT2A 1452/4885RAB9A 19/4885ALOX5 4821/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.